Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3556 AL 3570

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease

Cummings JL, Zhong K, Kinney JW, Heaney C, Moll-Tudla J, Joshi A, Pontecorvo M, Devous M, Tang A, Bena J.

Alzheimers Res Ther. 2016 Jan 29;8:4. doi: 10.1186/s13195-016-0173-2.

Heterozygous Chorein Deficiency in Probable Tau-negative Early-onset Alzheimer Disease

Lazarczyk MJ, Haller S, Gimelli S, Bena F, Giannakopoulos P.

Alzheimer Dis Assoc Disord. 2016 Jul-Sep;30(3):272-5. doi: 10.1097/WAD.0000000000000130.

Opportunities and challenges in developing relevant animal models for Alzheimer's disease

De Felice FG, Munoz DP.

Ageing Res Rev. 2016 Mar;26:112-4. doi: 10.1016/j.arr.2016.01.006. Epub 2016 Jan 30.

Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease

Boccardi V, Ruggiero C, Patriti A, Marano L.

J Alzheimers Dis. 2016;50(4):947-55. doi: 10.3233/JAD-150931.

Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation

Smith R, Wibom M, Olsson T, Hägerström D, Jögi J, Rabinovici GD, Hansson O.

J Alzheimers Dis. 2016;51(2):339-43. doi: 10.3233/JAD-151004.

Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients

Lee YM, Park JM, Lee BD, Moon E, Jeong HJ, Chung YI, Kim JH, Kim HJ, Mun CW, Kim TH, Kim YH.

J Clin Psychiatry. 2016 Jan;77(1):e8-13. doi: 10.4088/JCP.14m09740.

Nano-biosensors to detect beta-amyloid for Alzheimer's disease management

Kaushik A, Jayant RD, Tiwari S, Vashist A, Nair M.

Biosens Bioelectron. 2016 Jun 15;80:273-287. doi: 10.1016/j.bios.2016.01.065. Epub 2016 Jan 28.

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET

van Westen D, Lindqvist D, Blennow K, Minthon L, Nägga K, Stomrud E, Zetterberg H, Hansson O.

Sci Rep. 2016 Feb 9;6:20709. doi: 10.1038/srep20709.

SORL1 Is Associated with the Risk of Late-Onset Alzheimer's Disease: a Replication Study and Meta-Analyses

Zhang CC, Wang HF, Tan MS, Wan Y, Zhang W, Zheng ZJ, Kong LL, Wang ZX, Tan L, Jiang T, Tan L, Yu JT.

Mol Neurobiol. 2017 Apr;54(3):1725-1732. doi: 10.1007/s12035-016-9780-y. Epub 2016 Feb 13.

Visual function alterations in Alzheimer Disease: A case report

Pablo Piñero D, Monllor B, Moncho V, de Fez D.

Can J Ophthalmol. 2016 Feb;51(1):e16-8. doi: 10.1016/j.jcjo.2015.09.009.

Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review

El Haj M, Antoine P, Amouyel P, Lambert JC, Pasquier F, Kapogiannis D.

Ageing Res Rev. 2016 May;27:15-22. doi: 10.1016/j.arr.2016.02.002. Epub 2016 Feb 11.

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

Wattmo C, Minthon L, Wallin ÅK.

Alzheimers Res Ther. 2016 Feb 17;8:7. doi: 10.1186/s13195-016-0174-1.

Measuring Cortical Connectivity in Alzheimer's Disease as a Brain Neural Network Pathology: Toward Clinical Applications

Teipel S, Grothe MJ, Zhou J, Sepulcre J, Dyrba M, Sorg C, Babiloni C.

J Int Neuropsychol Soc. 2016 Feb;22(2):138-63. doi: 10.1017/S1355617715000995.

Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders

Godefroy O, Bakchine S, Verny M, Delabrousse-Mayoux JP, Roussel M, Pere JJ; REFLEX study group:.

J Alzheimers Dis. 2016;51(3):815-25. doi: 10.3233/JAD-150971.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias